AMANDA WEINMAN: Open Payments
NPI 1063511087 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 46 payments from 15 companies in 2025. Trend: 2023 $1,795 · 2024 $1,513 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $239 |
| Organon LLC | 4 | $185 |
| ABBVIE INC. | 10 | $180 |
| LEO Pharma Inc. | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| GENZYME CORPORATION | 3 | $56 |
| UCB, Inc. | 3 | $51 |
| Lilly USA, LLC | 2 | $38 |
| PFIZER INC. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: Otezla, SKYRIZI, VTAMA, DUPIXENT, Bimzelx, ANZUPGO, TALTZ, RINVOQ.
Industry payments across OR — which companies pay providers there.
